No Data
IGG: 2024 Annual Report
CITIC Securities: Maintain ZAI LAB's outperform industry rating with a Target Price of HKD 34.41.
CICC released a Research Report stating that it maintains the profit forecasts for ZAI LAB (09688) for 2025 and 2026. The firm maintains an outperform rating for the Industry, based on the DCF model, and keeps the Target Price for H/US stocks unchanged at HKD 34.41 / USD 44.24. On April 11, the company's partner Argenx announced that the subcutaneous injection form of Efgartigimod has been approved by the FDA for marketing in the USA. Additionally, on April 10, the company also presented the long-term data from the Efgartigimod ADAPTNXT (Phase B data) and ADAPT-SC+ studies at the American Academy of Neurology. Key points from CICC.
Hong Kong stocks fluctuate | Gaming stocks are among the top gainers. The regular issuance of game licenses in March. Institutions state that digital games are currently unaffected by tariffs.
The gaming stocks are performing well, as of the time of writing, NTES-S (09999) is up 10.36%, priced at 149.2 HKD; IDREAMSKY (01119) is up 6.85%, priced at 0.78 HKD; IGG (00799) is up 4.64%, priced at 3.16 HKD; XD INC (02400) is up 1.9%, priced at 29.5 HKD; Tencent (00700) is up 1.75%, priced at 443 HKD.
IGG Inc (HKG:799) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Shareholders Will Be Pleased With The Quality of IGG's (HKG:799) Earnings
IGG (0799.HK): Net income surged sevenfold! Multiple categories of new games are gearing up for a new growth cycle.
In the past year, the Global Game Industry has undergone structural adjustments, coupled with AI models like DeepSeek that are reconstructing game development paradigms, leading to intensified competition, rising customer acquisition costs, and major Game Developers facing dual challenges of content innovation and cost control.
of crashing?